BioMarin Pharmaceuticals
BMRN
BMRN
552 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 102 funds opening new positions, 186 increasing their positions, 175 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
552
Holders Change
+45
Holders Change %
+8.88%
% of All Funds
8.53%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
102
Increased
186
Reduced
175
Closed
46
Calls
$157M
Puts
$137M
Net Calls
+$19.8M
Net Calls Change
+$85.5M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$254M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$130M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$116M |
| 4 |
PA
Perceptive Advisors
New York
|
+$104M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$81.7M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$439M |
| 2 |
JPMorgan Chase & Co
New York
|
-$144M |
| 3 |
BlackRock
New York
|
-$125M |
| 4 |
Goldman Sachs
New York
|
-$59.3M |
| 5 |
DLPIC
Davide Leone & Partners Investment Company
London,
United Kingdom
|
-$55.3M |
